-
公开(公告)号:EP0215639A2
公开(公告)日:1987-03-25
申请号:EP86306988.6
申请日:1986-09-10
发明人: Bod, Peter , Harsanyi, Kalman , Csongor, Eva , Bogsch, Erik , Fekecs, Eva , Trischler, Ferenc , Domany, Gyorgy , Szabadkai, Istvan , Hegedus, Bela
IPC分类号: C07C303/34 , C07C257/14 , C07D277/48
CPC分类号: C07D277/48
摘要: Propionamidine derivatives of the formula (I)
wherein X is halogen are useful intermediates in the preparation of famotidine, an anti-ulcer agent.摘要翻译: 式(I)的丙酰脒衍生物...
其中X是卤素是制备法莫替丁(抗溃疡剂)的有用中间体。 -
2.
公开(公告)号:EP0595111B2
公开(公告)日:2001-08-16
申请号:EP93116542.7
申请日:1993-10-13
发明人: Bod, Péter, Dr. , Harsányi, Kálmán, Dr. , Trischler, Ferenc, Dr. , Fekecs, Eva , Csehi, Attila , Hegedus, Béla, Dr. , Mersich née Donát, Eva , Szabo née Komlosi, Györgyi , Horváth née Sziki, Erika
IPC分类号: C07D403/06 , C07D209/88 , C07D209/96
CPC分类号: C07D403/06 , C07D209/88
-
3.Morphologically homogenous forms of famotidine and processes for their preparation 失效
标题翻译: 化合物的生理学均匀形式及其制备方法公开(公告)号:EP0256747B1
公开(公告)日:1992-11-11
申请号:EP87306882.9
申请日:1987-08-04
发明人: Bod, Peter , Harsanyi, Kalman , Hegedus, Bela , Bogsch, Erik , Fekecs, Eva , Peter, Imre , Aracs, Zsuzsanna , Miszori, Sandor , Stiller, Maria
IPC分类号: C07D277/48 , A61K31/425
CPC分类号: C07D277/48 , C07D277/42
-
公开(公告)号:EP0215639A3
公开(公告)日:1988-01-07
申请号:EP86306988
申请日:1986-09-10
发明人: Bod, Peter , Harsanyi, Kalman , Csongor, Eva , Bogsch, Erik , Fekecs, Eva , Trischler, Ferenc , Domany, Gyorgy , Szabadkai, Istvan , Hegedus, Bela
IPC分类号: C07C143/72 , C07D277/48
CPC分类号: C07D277/48
摘要: Propionamidine derivatives of the formula (I)
wherein X is halogen are useful intermediates in the preparation of famotidine, an anti-ulcer agent.-
5.Morphologically homogenous forms of famotidine and processes for their preparation 失效
标题翻译: 法莫替丁的形态均匀的形式和它们的制备方法公开(公告)号:EP0256747B2
公开(公告)日:2001-11-28
申请号:EP87306882.9
申请日:1987-08-04
发明人: Bod, Peter , Harsanyi, Kalman , Hegedus, Bela , Bogsch, Erik , Fekecs, Eva , Peter, Imre , Aracs, Zsuzsanna , Miszori, Sandor , Stiller, Maria
IPC分类号: C07D277/48 , A61K31/425
CPC分类号: C07D277/48 , C07D277/42
-
公开(公告)号:EP0215639B1
公开(公告)日:1990-08-29
申请号:EP86306988.6
申请日:1986-09-10
发明人: Bod, Peter , Harsanyi, Kalman , Csongor, Eva , Bogsch, Erik , Fekecs, Eva , Trischler, Ferenc , Domany, Gyorgy , Szabadkai, Istvan , Hegedus, Bela
IPC分类号: C07C303/34 , C07C257/14 , C07D277/48
CPC分类号: C07D277/48
-
7.Morphologically homogenous forms of famotidine and processes for their preparation 失效
标题翻译: 形态形成同源物冯法莫替丁和Verfahren zu deren Herstellung。公开(公告)号:EP0256747A1
公开(公告)日:1988-02-24
申请号:EP87306882.9
申请日:1987-08-04
发明人: Bod, Peter , Harsanyi, Kalman , Hegedus, Bela , Bogsch, Erik , Fekecs, Eva , Peter, Imre , Aracs, Zsuzsanna , Miszori, Sandor , Stiller, Maria
IPC分类号: C07D277/48 , A61K31/425
CPC分类号: C07D277/48 , C07D277/42
摘要: The invention relates to two morphologically homogeneous forms of famotidine [N-sulfamoyl-3-(2-guanidino-thiazole-4-yl-methylthio)-propionamidine]. Said forms are prepared by selective crystallisation or precipitation.
摘要翻译: 本发明涉及法莫替丁[N-氨磺酰基-3-(2-胍基 - 噻唑-4-基 - 甲硫基) - 丙脒]的两种形态均匀形式。 所述形式通过选择性结晶或沉淀制备。
-
8.
公开(公告)号:EP0595111B1
公开(公告)日:1997-09-10
申请号:EP93116542.7
申请日:1993-10-13
发明人: Bod, Péter, Dr. , Harsányi, Kálmán, Dr. , Trischler, Ferenc, Dr. , Fekecs, Eva , Csehi, Attila , Hegedus, Béla, Dr. , Mersich née Donát, Eva , Szabo née Komlosi, Györgyi , Horváth née Sziki, Erika
IPC分类号: C07D403/06 , C07D209/88 , C07D209/96
CPC分类号: C07D403/06 , C07D209/88
-
9.Carbazolone derivatives and process for preparing the same 失效
标题翻译: Carbazolon - Derivate und Verfahren zu ihrer Herstellung。公开(公告)号:EP0595111A1
公开(公告)日:1994-05-04
申请号:EP93116542.7
申请日:1993-10-13
发明人: Bod, Péter, Dr. , Harsányi, Kálmán, Dr. , Trischler, Ferenc, Dr. , Fekecs, Eva , Csehi, Attila , Hegedus, Béla, Dr. , Mersich née Donát, Eva , Szabo née Koml si, Györgyi , Horváth née Sziki, Erika
IPC分类号: C07D403/06 , C07D209/88 , C07D209/96
CPC分类号: C07D403/06 , C07D209/88
摘要: The invention relates to carbazolone derivatives of the formula
wherein
A stands for a group of formula
wherein R means a hydroxyl or 2-methyl-1 H-imidazol-1-yl group;
B represents a group of formula
wherein R 1 means hydrogen or a methyl or ethyl group; or A and B together form a group of formula
wherein R 2 means a methyl or ethyl group; or
A and B together form a group of formula
The above compounds are useful intermediates in the synthesis of ondansetron of formula
chemically 9-methyl-3-[(2-methyl-1 H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one.
The invention further relates to a novel process for the preparation of compounds of the formula (I), wherein A and B are the same as in formula (I).摘要翻译: 本发明涉及式CHEM的咔唑酮衍生物,其中A代表式-CH 2 -R(V)基团,其中R表示羟基或2-甲基-1H-咪唑-1-基; B表示式CHEM的基团,其中R 1表示氢或甲基或乙基; 或A和B一起形成式CHEM的基团,其中R 2表示甲基或乙基; 或A和B一起形成式
的化合物上述化合物是化学式9-甲基-3 - [(2-甲基-1H-咪唑-1-基)苯并噻唑烷酮的合成昂丹司琼的有用中间体。 甲基] -1,2,3,9-四氢-4H-咔唑-4-酮。 本发明还涉及制备式(I)化合物的新方法,其中A和B与式(I)中相同。
-
-
-
-
-
-
-
-